Table II.
Duration of treatment with denosumab in the present study.
| Group | Patients, n | Mean treatment time, months (range) |
|---|---|---|
| Total | 35 | 7.4 (2–16) |
| Surgery | 17 | 7.2 (5–12) |
| No surgery | 18 | 7.8 (2–16) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.